Tolu reporters

  Nigeria’s National Health Insurance Authority (NHIA) has announced an expanded health insurance framework designed to dramatically slash out-of-pocket expenses for cancer diagnosis, radiotherapy, and targeted oncology medications across the country. The new policy package, rolled out by the authority to mark Breast Cancer Awareness Month, introduces an 80% cost-reduction scheme for essential cancer medications, alongside increased financial subsidies for radiotherapy treatments ranging from ₦400,000 to complete bill coverage for eligible beneficiaries. A Public-Private Cost-Sharing Benchmark At the center of the expanded coverage is a co-financing partnership between the NHIA and global pharmaceutical leader Roche. Under this tripartite agreement, Swiss drugmaker Roche absorbs 50% of the market cost for high-value oncology drugs. The NHIA subsidizes an additional 30%, leaving eligible enrollees responsible for paying just 20% of the total retail price at accredited health facili...

  The Federal Government has inaugurated ten state-of-the-art medical diagnostic centres and three specialized cancer treatment facilities distributed across ten states. The landmark commissioning represents a major operational milestone under President Bola Ahmed Tinubu’s administration, aimed at reversing medical tourism, modernizing tertiary healthcare, and decentralizing access to life-saving diagnostic and oncology services. Strategic Infrastructure Expansion The newly commissioned infrastructure includes ten modern diagnostic centres equipped with advanced imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT) scanners, digital mammography, and fully automated clinical laboratories. In addition, three comprehensive cancer treatment centres have been fully equipped with modern linear accelerators and radiotherapy equipment to support early detection, chemotherapy, and radiation therapy. Speaking during the commissioning ceremony in Bauchi, Coor...

The World Health Organization (WHO) released its latest Global Health Estimates, revealing that just 10 diseases accounted for 33 million deaths worldwide in a single year. The figure represents 54% of the estimated 61 million global fatalities recorded, highlighting a massive concentration of mortality driven predominantly by noncommunicable diseases (NCDs) alongside persistent infectious threats. The report underscores a profound shift in global health dynamics over the past two decades. Noncommunicable conditions such as heart disease, stroke, and cancer now account for 74% of all global deaths, up from 58% in 2000. Eight of the top 10 leading causes of death worldwide fall into the NCD category, reflecting longer life expectancies globally but also an alarming rise in chronic, lifestyle- and age-related illnesses. Cardiovascular Diseases Remain the World’s Biggest Killers Leading the list of fatal illnesses are cardiovascular conditions, which continue to hold the title of the worl...

  The National Agency for Food and Drug Administration and Control (NAFDAC) has revealed that Nigeria’s current lack of local vaccine manufacturing capacity remains the primary hurdle preventing the agency from attaining World Health Organization (WHO) Maturity Level 4 status. Speaking through a statement issued on Sunday by NAFDAC’s Resident Media Consultant, Sayo Akintola, the Director-General of the agency, Prof. Mojisola Adeyeye, explained that while Nigeria has successfully met eight of the nine regulatory functions required for WHO’s highest benchmark, the final function Vaccine Lot Release cannot be operationalized without domestic production facilities. The Last Mile to Maturity Level 4 WHO Maturity Level 4 (ML4) represents the highest global regulatory standard, operating at an advanced level of performance with continuous improvement. Achieving ML4 status for NAFDAC would allow regulatory decisions and approvals made in Nigeria to be recognized globally, enabling local ph...

  On September 26, health organizations, youth advocates, and policymakers across the globe commemorated World Contraception Day (WCD) 2026. Under this year's official theme, “No Barriers, Just Choices: Contraceptive Access Now,” the international campaign is mobilizing to dismantle global inequities, financial barriers, and systemic stigmas that currently prevent over 250 million women from accessing safe and effective family planning methods. First established in 2007 by a coalition of international non-governmental organizations, scientific bodies, and public health institutions, World Contraception Day centers on a unified vision: a world where every pregnancy is wanted. Two decades into the initiative, global leaders are shifting focus from basic awareness to structural implementation and autonomy. Dismantling Obstacles to Reproductive Freedom Despite decades of advocacy and technological advancement in modern birth control ranging from long-acting reversible contraceptives (...

  A severe supply deficit of the newly introduced, long-acting injectable HIV prevention drug, Lenacapavir, has sparked widespread concern among sex workers and high-risk populations across several states in Nigeria. Barely six months after the Federal Government of Nigeria flagged off a pilot distribution of the twice-yearly pre-exposure prophylaxis (PrEP) jab, health facilities in states including Benue, Kwara, Gombe, and Cross River have completely exhausted their allocated stocks, leaving waiting lists growing and vulnerable users at risk. A Breakthrough Tool Meets Unprecedented Demand The Federal Government received an initial batch of 11,520 doses of Lenacapavir on March 19, 2026, distributing them five days later across 10 pilot locations Benue, Kwara, Akwa Ibom, Cross River, Gombe, Anambra, Ebonyi, Kano, Lagos, and the Federal Capital Territory. Unlike traditional oral PrEP, which requires users to strictly adhere to a daily pill regimen, Lenacapavir is administered as a su...

  The Africa Centres for Disease Control and Prevention ( Africa CDC ) has officially rolled out a groundbreaking 10-year continental strategic plan designed to drastically curb deaths and severe health complications from sickle cell disease (SCD) and other inherited blood disorders. The ambitious roadmap directly targets one of the continent’s most severe yet historically overlooked public health crises. Sub-Saharan Africa bears the vast majority of the global sickle cell burden, accounting for more than 75 percent of all children born with the condition worldwide. Public health experts estimate that between 300,000 and 400,000 infants are born with the genetic blood disorder across Africa each year. Without immediate diagnosis and therapeutic intervention, up to 80 percent of children born with sickle cell disease on the continent die before reaching their fifth birthday. Those who survive early childhood frequently endure excruciating lifelong pain crises, organ damage, stroke r...

  Healthcare leaders, international delegates, and frontline practitioners around the world are marking World Pharmacists Day under the official 2026 global campaign theme, “Empowering Pharmacists for Healthier Futures.” Organized annually by the International Pharmaceutical Federation (FIP) commemorating the organization’s establishment on September 25, 1912 the 2026 observatory serves as both a global celebration and an urgent call to action. Today’s events, concluding World Pharmacy Week (September 19–25), emphasize a rapid paradigm shift in modern medicine: moving pharmacists away from traditional pill-dispensing roles toward becoming fully integrated, primary care providers and health system decision-makers. Beyond the Counter: A Profession Transformed As health systems worldwide strain under aging populations, an accelerating burden of non communicable diseases, and rising operational costs, the role of the neighborhood pharmacist has expanded significantly. In community cli...

  The MTN Group Foundation and the Gates Foundation have unveiled a joint $25 million AI Maternal Health initiative. Formally launched on the sidelines of the 81st session of the United Nations General Assembly, the four-year program titled the Nigeria Maternal Health Multiplier aims to leverage artificial intelligence, mobile technology, and telecommunications infrastructure to transform maternal healthcare delivery across Nigeria.    Running from 2026 through 2030, the $25 million commitment combines direct funding and in-kind resources from both organizations. By the end of the four-year deployment, the platform is projected to reach at least 500,000 pregnant women, equip 5,000 frontline healthcare workers with real-time digital clinical tools, and upgrade telecom infrastructure for 500 primary health centers.    A Response to a Global Crisis The coalition targets Nigeria due to its disproportionate burden in global health statistics. According to data from t...

  Nigerian healthcare professionals have successfully performed the West African sub-region’s first-ever tele-robotic surgery.    The pioneer operation, a robot-assisted right radical nephrectomy performed to extract a cancerous kidney tumor, was executed on a patient lying in an operating theater in Abuja. Meanwhile, the lead surgeon controlled the robotic instruments in real time from a master console in Mowe, Ogun State, roughly 500 kilometers away.    The historic procedure was carried out through a trilateral partnership involving Redeemer’s Health Village (RHV) in Ogun State, medical technology provider RoboMed Global, and Nisa Premier Hospital in Abuja.    The operation utilized the advanced Toumai robotic surgical console situated at Redeemer’s Health Village. Operating the master unit was Professor Obi Ekwenna-Davis, a US-based Professor of Urology and Transplantation and Co-Founder of RoboMed Global.    Hundreds of kilometers away a...

The Federal Government of Nigeria has officially adopted Health Technology Assessment (HTA) as a national framework to guide healthcare coverage and spending. The initiative was formally flagged off in Abuja during the inauguration of the HTA Steering Committee. The move represents a structural pivot toward evidence-based healthcare financing as the country seeks to accelerate progress toward Universal Health Coverage (UHC) while protecting citizens from catastrophic medical expenses. A Systematic Shift Toward "Strategic Purchasing " Under the leadership of the National Health Insurance Authority (NHIA) and the Federal Ministry of Health and Social Welfare, HTA introduces a multidisciplinary approach to evaluate the clinical effectiveness, economic value, safety, and equity impact of medical interventions before they are funded or integrated into national benefit packages. Speaking at the launch, the  Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pat...